Scholarlink

<p><i>Vibrio cholerae</i> remains a global health threat, driven by epidemic strains and sporadic infections associated with non-toxigenic lineages. We report the genomic characterization of a <i>V. cholerae</i> O1 Ogawa isolate (V86/24) recovered from a human case in Brazil (2024) with no travel history. We performed antimicrobial susceptibility testing, whole-genome sequencing (WGS), and in silico analyses, including SNP-based phylogenetic and pangenome analyses (V86/24 + 62 public genomes; total <i>N</i> = 63), resistome, and virulome. The isolate showed intermediate susceptibility to imipenem but was susceptible to other tested antimicrobials. WGS identified V86/24 as sequence type ST170, lineage L3b.2, sublineage MX-2. It harbors pathogenicity islands VPI-1 and VPI-2 but lacks seventh-pandemic-associated islands (VSP-1, VSP-2) and classical CTXΦ-associated toxin genes (<i>ctxA</i>, <i>ctxB</i>, <i>ace</i>, <i>zot</i>). Pangenome analysis revealed 4,485 gene clusters; V86/24 carried eight unique clusters primarily mapped to a prophage-like region. Resistome profiling identified the intrinsic <i>varG</i> metallo-β-lactamase gene. The virulome retained alternative virulence and colonization factors, including TCP/ACF, RTX/MARTX, and an extensive type VI secretion system. Phylogenetically, V86/24 clusters with ST170 isolates circulating in the Americas, distinctly separated from seventh-pandemic lineages. Non-toxigenic <i>V. cholerae</i> O1 lineages can cause human infection. These findings underscore the critical need for integrated genomic surveillance, including pangenome profiling, beyond classical toxigenicity markers to detect emerging risks prior to epidemic spread.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genomic and epidemiological insights into a non-toxigenic Vibrio cholerae O1 Ogawa from an autochthonous case in Brazil

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月15日

查看全文
  • André Felipe Santos,
  • Pedro Panzenhagen,
  • Verônica Dias Gonçalves,
  • Laura Fabiana Vieira do Amparo,
  • Joyce Figueira Pereira de Souza,
  • Maria Eduarda Moreira,
  • Maria Luiza Paula Pereira,
  • Emily Moraes Roges,
  • Lucia Helena Berto,
  • Dália dos Rodrigues

摘要

Vibrio cholerae remains a global health threat, driven by epidemic strains and sporadic infections associated with non-toxigenic lineages. We report the genomic characterization of a V. cholerae O1 Ogawa isolate (V86/24) recovered from a human case in Brazil (2024) with no travel history. We performed antimicrobial susceptibility testing, whole-genome sequencing (WGS), and in silico analyses, including SNP-based phylogenetic and pangenome analyses (V86/24 + 62 public genomes; total N = 63), resistome, and virulome. The isolate showed intermediate susceptibility to imipenem but was susceptible to other tested antimicrobials. WGS identified V86/24 as sequence type ST170, lineage L3b.2, sublineage MX-2. It harbors pathogenicity islands VPI-1 and VPI-2 but lacks seventh-pandemic-associated islands (VSP-1, VSP-2) and classical CTXΦ-associated toxin genes (ctxA, ctxB, ace, zot). Pangenome analysis revealed 4,485 gene clusters; V86/24 carried eight unique clusters primarily mapped to a prophage-like region. Resistome profiling identified the intrinsic varG metallo-β-lactamase gene. The virulome retained alternative virulence and colonization factors, including TCP/ACF, RTX/MARTX, and an extensive type VI secretion system. Phylogenetically, V86/24 clusters with ST170 isolates circulating in the Americas, distinctly separated from seventh-pandemic lineages. Non-toxigenic V. cholerae O1 lineages can cause human infection. These findings underscore the critical need for integrated genomic surveillance, including pangenome profiling, beyond classical toxigenicity markers to detect emerging risks prior to epidemic spread.